Hemopressin is an inverse agonist of CB1 cannabinoid receptors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 51, 2007, Pages 20588-20593

  Heimann, Andrea S ^a   Gomes, Ivone ^b   Dale, Camila S ^c   Pagano, Rosana L ^c   Gupta, Achla ^b   De Souza, Laura L ^a   Luchessi, Augusto D ^a   Castro, Leandro M ^d   Giorgi, Renata ^c   Rioli, Vanessa ^c,d   Ferro, Emer S ^d   Devi, Lakshmi A ^b  

^a Proteimax Biotechnology ^*  (Brazil)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c INSTITUTO BUTANTAN   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drugs of abuse; G protein coupled receptors; Inflammatory pain; Rimonabant

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR; HEMOPRESSIN; PROLYLVALYLASPARAGINYLPHENYLALANYLLYSYLPHENYLALANYLLEUCYLSERYLHISTIDINE; RIMONABANT; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HYPERALGESIA; MALE; NERVE FIBER GROWTH; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; WRITHING TEST;

CELL LINE; DRUG INVERSE AGONISM; HEMOGLOBINS; HUMANS; LIGANDS; PEPTIDE FRAGMENTS; RECEPTOR, CANNABINOID, CB1;

RODENTIA;

EID: 38049117749     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0706980105     Document Type: Article

References (41)

1. Begg M, Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Mo FM, Liu J, Kunos G (2005) Pharmacol Ther 106:133-145.
2. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Nature 346:561-564.
3. Munro S, Thomas KL, Abu-Shaar M (1993) Nature 365:61-65.
4. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, et al. (2005) Science 310:329-332.
5. Zhang J, Hoffert C, Va HK, Groblewski T, Ahmad S, O'Donnell D (2003) Eur J Neurosci 17:2750-2754.
6. Di Marzo V, Petrosino S (2007) Curr Opin Lipidol 18:129-140.
7. Battista N, Fezza F, Finazzi-Agro A, Maccarrone M (2006) Ital J Biochem 55:283-289.
8. Boyd ST (2006) Pharmacotherapy 26:218S-221S.
9. Iversen L, Chapman V (2002) Curr Opin Pharmacol 2:50-55.
10. Gilron I, Coderre TJ (2007) Expert Opin Emerg Drugs 12:113-126.
11. Walker JM, Huang SM (2002) Pharmacol Ther 95:127-135.
12. Rioli V, Gozzo FC, Heimann AS, Linardi AS, Krieger JE, Shida CS, Almeida PC, Hyslop S, Eberlin MN, Ferro ES (2003) J Biol Chem 278:8547-8555.
13. Ferro ES, Hyslop S, Camargo AC (2004) J Neurochem 91:769-777.
14. Heimann AS, Favarato MH, Gozzo FC, Rioli V, Carreno FR, Eberlin MN, Ferro ES, Krege ES, Krieger JE (2005) Physiol Genomics 20:173-182.
15. Dale CS, Pagano R de L, Rioli V, Hyslop S, Giorgi R, Ferro ES (2005) Peptides 26:431-436.
16. Gupta A, Decaillot FM, Gomes I, Tkalych O, Heimann AS, Ferro ES, Devi LA (2007) J Biol Chem 282:5116-5124.
17. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, et al. (1997) J Biol Chem 272:22330-22339.
18. Jordan JD, He JC, Eungdamrong NJ, Gomes I, Ali W, Nguyen T, Binova TG, Philips MR, Devi LA, Iyengar R (2005) J Biol Chem 280:11413-11421.
19. He JC, Gomes I, Nguyen T, Jayaram G, Ram PT, Devi LA, Iyengar R (2005) J Biol Chem 280:33426-33434.
20. Costa B, Trovato AE, Colleoni M, Giagnoni G, Zarini E, Croci T (2005) Pain 116:52-61.
21. Croci T, Landi M, Galzin AM, Marini P (2003) Br J Pharmacol 140:115-122.
22. Croci T, Zarini E (2007) Br J Pharmacol 150:559-566.
23. Cheng Y, Hitchcock SA (2007) Expert Opin Investig Drugs 16:951-965.
24. Hohmann AG, Suplita RL, 2nd (2006) AAPS J 8:E693-E708.
25. Lever IJ, Rice AS (2007) Handb Exp Pharmacol 177:265-306.
26. Fox A, Bevan S (2007) Expert Opin Invest Drugs 14:695-703.
27. Petrosino S, Palazzo E, de Novellis V, Bisogno T, Rossi F, Maione S, Di Marzo V (2006) Neuropharmacology 52:415-422.
28. Patwardhan AM, Jeske NA, Price TJ, Gamper N, Akopian AN, Hargreaves KM (2006) Proc Natl Acad Sci USA 103:11393-11398.
29. Karaki H, Doi K, Sugano S, Uchiwa H, Sugai R, Murakami U, Takemoto S (1990) Comp Biochem Physiol C 96:367-371.
30. Karaki H, Kuwahara M, Sugano S, Doi C, Doi K, Matsumura N, Shimizu T (1993) Comp Biochem Physiol C 104:351-353.
31. Shu C, Shen H, Hopfer U, Smith DE (2001) Drug Metab Dispos 29:1307-1315.
32. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H, Nurminen ML (2001) J Physiol Pharmacol 52:745-754.
33. Seppo L, Jauhiainen T, Poussa T, Korpela R (2003) Am J Clin Nutr 77:326-330.
34. Che FY, Lim J, Pan H, Biswas R, Fricker LD (2005) Mol Cell Proteom 4:1391-1405.
35. Heimann AS, Favarato MH, Gozzo FC, Rioli V, Carreno FR, Eberlin MN, Ferro ES, Krege JH, Krieger JE (2005) Physiol Genom 20:173-182.
36. Gomes I, Filipovska J, Devi LA (2003) Methods Mol Med 84:157-183.
37. Unterwald EM, Cox BM, Kreek MJ, Cote TE, Izenwasser S (1993) Synapse 15:33-38.
38. Zimmermann M (1983) Pain 16:109-110.
39. Randall LO, Selitto JJ (1957) Arch Int Pharmacodyn Ther 111:409-419.
40. Broadhurst PL (1960) Fortschr Psychosom Med 1:63-69.
41. Brigatte P, Hoffmann FA, Bernardi MM, Giorgi R, Fernandes I, Takehara HA, Barros SB, Almeida MG, Cury Y (2001) Toxicon 39:1399-1410.